| Heading: |
Prostate Cancer: Screening |
| Question ID: |
1750563 |
| UIN: |
20722 |
| House: |
Commons |
| Date tabled: |
2024-12-17 |
| Asking Member ID: |
5248 |
| Asking Member display name: |
Luke Murphy
|
| Asking Member handle: |
LukeMLabour
|
| Asking Member Twitter reference: |
@LukeMLabour
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of introducing a national prostate-specific antigen screening programme for prostate cancer in the UK. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-01-06 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Screening for prostate cancer is currently not recommended by the UK National Screening Committee (UK NSC). This is because of the inaccuracy of the current best test, called the Prostate Specific Antigen (PSA). A PSA-based screening programme could harm ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |